Research Roundup

Debbie Rigby rounds up the latest in research news Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections A large population-based cohort study using US-based databases has shown that the risk for severe and nonsevere UTI events among those initiating SGLT-2 inhibitor therapy was similar to that among patients initiating treatment with other

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist directly imported hormone and ED treatments
Next Fire-affected pharmacies step in to help